Back
Pfizer 10K Form
Sell
32
PFE
Pfizer
Last Price:
$26.20
Seasonality Move:
3.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2025-03-15 | 10K | PFE/Pfizer Annual |
| 2025-02-15 | 10K | PFE/Pfizer Annual |
| 2024-11-04 | 10Q | PFE/Pfizer Quarterly |
| 2024-08-05 | 10Q | PFE/Pfizer Quarterly |
| 2024-05-08 | 10Q | PFE/Pfizer Quarterly |
| 2024-02-22 | 10K | PFE/Pfizer Annual |
Receive PFE News And Ratings
See the #1 stock for the next 7 days that we like better than PFE
PFE Financial Statistics
Sales & Book Value
| Annual Sales: | $63.6B |
|---|---|
| Cash Flow: | $5.8B |
| Price / Cash Flow: | 15.18 |
| Annual Sales: | $15.56 |
| Price / Book: | 1.68 |
Profitability
| EPS (TTM): | 1.41000 |
|---|---|
| Net Income (TTM): | $8B |
| Gross Margin: | $45.8B |
| Return on Equity: | 8.91% |
| Return on Assets: | 3.66% |
Pfizer Earnings Forecast
Key Pfizer Financial Ratios
-
The Gross Profit Margin over the past 41 years for PFE is 71.94%.
-
The Selling, General & Administrative Expenses for PFE have been equal to 23.15% of Gross Profit Margin.
-
The Research & Development expenses have been 17.01% of Revenue.
-
The Interest Expense is 38.49% of Operating Income.
-
The Net Earning history of PFE is 12.62% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 27 years.
Pfizer Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | PFE |
| CUSIP: | 717081 |
| Website: | pfizer.com |
Debt
| Debt-to-Equity Ratio: | 0.72 |
|---|---|
| Current Ratio: | 1.17 |
| Quick Ratio: | 0.82 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.57 |
|---|---|
| Forward P/E Ratio: | 8.58 |